Solo información educativa. Los usos de investigación pueden no tener aprobación de la FDA. No es asesoramiento médico ni un plan de tratamiento.
Bromelain is a mixture of proteolytic (cysteine protease) enzymes extracted from the stem and fruit of the pineapple plant (Ananas comosus). It has been researched for its systemic effects beyond digestion, including inflammatory signaling modulation, immune pathway interactions, and fibrinolytic activity. It is used as a dietary supplement and is also studied as a complementary agent in various clinical research contexts.
Áreas de investigación
Inflammatory Signaling Pathway ResearchStudies investigate bromelain's effects on pro-inflammatory signaling cascades, including modulation of NF-κB pathway activity, prostaglandin synthesis research, and cytokine regulation in both in vitro and in vivo inflammation models.
Fibrinolytic & Coagulation Pathway ResearchResearch examines bromelain's fibrinolytic properties, including its effects on fibrin degradation signaling, platelet aggregation pathway research, and its interaction with coagulation cascade investigations.
Proteolytic Enzyme Activity ResearchResearchers investigate bromelain's systemic proteolytic activity, exploring how its enzyme activity affects protein digestion efficiency, mucolytic signaling pathways, and potential interactions with drug absorption and bioavailability research.
Tissue Repair & Edema Pathway ResearchStudies examine its potential role in post-injury tissue repair signaling, edema reduction pathway research, and its effects on tissue-level inflammatory resolution signaling in surgical and trauma recovery models.